Synthesis and antifungal activity of a novel series of 13-(4- isopropylbenzyl)berberine derivatives

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 22, 2010, Pages 6551-6554

  Park, Ki Duk ^a,b   Cho, Sung Jin ^a,c   Moon, Jae Sun ^a   Kim, Sung Uk ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

13 (4 Isopropylbenzyl)berberine; Antifungal activity; Berberine derivatives; Human pathogenic fungi

Indexed keywords

13 (4 ISOPROPYLBENZYL)BERBERINE; 9 O BUTYL 13 (4 ISOPROPYLBENZYL)BERBERINE; ALKYL GROUP; AMPHOTERICIN B; ANTIFUNGAL AGENT; BERBERINE DERIVATIVE; METHYL GROUP; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS; CANDIDA; CRYPTOCOCCUS; CRYPTOCOCCUS NEOFORMANS; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; FUNGUS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIFUNGAL AGENTS; ASPERGILLUS; BERBERINE; CANDIDA; CRYPTOCOCCUS NEOFORMANS; MICE; MICROBIAL SENSITIVITY TESTS;

ASPERGILLUS; CANDIDA; FILOBASIDIELLA NEOFORMANS; FUNGI; MUS;

EID: 77958047965     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.09.045     Document Type: Article

References (17)

1. M.D. Richardson J. Antimicrob. Chemother. 56 2005 i5
2. T. Brautaset, H. Sletta, A. Nedal, S.E.F. Borgos, K.F. Degnes, I. Bakke, O. Volokhan, O.N. Sekurova, I.D. Treshalin, E.P. Mirchink, A. Dikiy, T.E. Ellingsen, and S.B. Zotchev Chem. Biol. 15 2008 1198
3. N.H. Georgopapadakou, and T.J. Walsh Antimicrob. Agents Chemother. 40 1996 279
4. M.D. Richardson J. Antimicrob. Chemother. 28 1991 1
5. P.E. Verweij, E. Snelders, G.H.J. Kema, E. Mellado, and J.G.M. Melchers Lancet Infect. Dis. 6 2009 789
6. A.H. Groll, A.J. De Lucca, and T.J. Walsh Trends Microbiol. 6 1998 117
7. K.S. Park, K.C. Kang, J.H. Kim, D.J. Adams, T.N. Johng, and Y.K. Paik J. Antimicrob. Chemother. 43 1999 667
8. X. Bian, L. He, and G. Yang Bioorg. Med. Chem. Lett. 16 2006 1380
9. Y. Xu, Y. Wang, L. Yan, R.M. Liang, B.D. Dai, R.J. Tang, P.H. Gao, and Y.Y. Jiang J. Proteome Res. 8 2009 5296
10. Y. Han, and J.H. Lee Biol. Pharm. Bull. 28 2005 541
11. H. Quan, Y.Y. Cao, Z. Xu, J.X. Zhao, P.H. Gao, X.F. Qin, and Y.Y. Jiang Antimicrob. Agents Chemother. 50 2006 1096
12. K.S. Park, K.C. Kang, K.Y. Kim, P.Y. Jeong, J.H. Kim, D.J. Adams, J.H. Kim, and Y.K. Paik J. Antimicrob. Chemother. 47 2001 513
13. K.D. Park, J.H. Lee, S.H. Kim, T.H. Kang, J.S. Moon, and S.U. Kim Bioorg. Med. Chem. Lett. 16 2006 3913
14. National Committee for Clinical Laboratory Standards. Approved Standard M27-A2, NCCLS, Wayne, PA, USA, 2002.
15. National Committee for Clinical Laboratory Standards. Approved Standard M38-A, NCCLS, Wayne, PA, USA, 2002.
16. H. Mizuta, S. Naruto, and H. Nishimura Chem. Pharm. Bull. 35 1987 2238
17. M. Shamma, and M. Rahimizadeh J. Nat. Prod. 49 1986 398